Therefore, co-expression of alternative p53-isoforms provides an additional mechanism to modulate p53α ́s tumor suppressor functions beyond TP53 gene mutations mostly affecting the DNA-binding domain (DBD) [17]. The gene discussed is TP53; the disease is neoplasm.